Global Initiative on Health and the Economy
The Global Initiative on Health and the Economy (GIHE) champions public health, trade, and regulatory policies that enable companies in the healthcare sector to deliver solutions that benefit people around the world. We spotlight the unique value of the private sector and advocate for investment in public health as a means to directly drive economic resiliency and growth.
Latest Publication:
Countries seeking to improve equitable access to health products and technologies should look beyond local manufacturing.
The Global Initiative on Health and the Economy
Video
Increasing rates of chronic disease around the world coupled with the COVID-19 pandemic are having an alarming impact on public health, workforce productivity, global development, and economic growth. To reverse this trend, GIHE is championing health systems strengthening policies and private sector partnership to deliver solutions that serve individuals, support communities, and benefit countries around the world.
Our views
- Digital health has the potential to address unmet medical needs Greater private and public investments to support new digital health tools is imperative for the advancement of global health. The public and private sector must work together to bridge the digital gaps present in societies and ensure that disadvantaged populations worldwide can benefit from new digital health tools. Read more
- Strengthening health systems leads to greater resiliency Not only will strong and resilient health systems withstand public health emergencies, but they will buffer economic losses and sustain growth. Resilient health systems protect against both infectious disease threats as well as rising chronic disease burdens.Read more
- Health investment drives economic growth Healthcare investments should be seen as a tool to grow the economy, rather than a budgetary cost. Non-communicable diseases and the ongoing COVID-19 pandemic represent two of the most serious drags on economic growth, and their broad impacts are growing rapidly.Read more
- Public-private partnerships are keyThere needs to be a trusted partnership with the private sector, whose role in health systems has been of critical importance during the pandemic via the development, production, and mass distribution of high-quality vaccines, therapeutics, diagnostics, and PPE. Read more
Latest Content
Support Anti-Terrorism by Fostering Effective Technologies Act (SAFETY Act) comment request (docket number DHS–2019–0010)1
WASHINGTON, D.C. — The U.S. Chamber of Commerce and China's Hainan Province signed a memorandum of understanding that will serve as a foundation for cooperation in the fields of health. The agreement establishes a strategic partnership that will drive Hainan Province’s medical and health industries to achieve breakthroughs in the development and promotion of market-based healthcare solutions. It will also introduce U.S.
This statement is issued by the signatory organisations listed below and not by the Global Business Coalition, as an organisation
This report estimates the economic cost of health-related productivity losses, profiling eighteen countries, ranging from industrialized markets such as the United States and Japan, to developing markets such as Kenya and Indonesia.
This report provides estimates of the economic cost due to productivity losses arising from absenteeism, presenteeism and early retirement due to ill health. For South Africa, these losses equate to a total of 6.7% of GDP in 2015 as shown in Table ES 1, increasing to 7.0% of GDP by 2030.
The World Health Organization predicts NCDs will become the leading cause of death in Sub-Saharan Africa by 2030. Productivity losses related to ill health cost South Africa 6.7% GDP a year, rising to 7.0% GDP by 2030.
This report provides estimates of the economic cost due to productivity losses arising from absenteeism, presenteeism and early retirement due to ill health. For Saudi Arabia, these losses equate to a total of 9.7% of GDP by 2030 as shown in Table ES1. This is the largest impact of any of the countries included in this study as comparator countries. The majority are middle income developing countries from around the globe, although the US, Japan and Singapore are also included.
This report provides estimates of the economic cost due to productivity losses arising from absenteeism, presenteeism and early retirement due to ill health. For Jiangsu, these losses equate to a total of 5.3% of GDP in 2015, as shown in Table ES 1, increasing to 6.3% of GDP by 2030.
This report provides estimates of the economic cost due to productivity losses arising from absenteeism, presenteeism and early retirement due to ill health. For Brazil these losses equate to a total of 8.7% of GDP as shown in Table ES 1. This puts Brazil towards the upper end of the range for a group of 10 other countries that includes some of its Latin American peers as well as other middle income developing countries from other parts of the world.
Out of the total 605,000 deaths in Mexico in 2014, NCDs are accountable for 77% (465,850) and accidents and injuries contribute another 12%.